1 min read
Nuo Therapeutics Posts $1.9 Million in Q3 Revenue, Up 84.5%
The company’s GAAP loss per share was $0.01 for the quarter.

Nuo Therapeutics (AURX) posted $1.9 million in third-quarter revenue, 84.5% higher than a year earlier. Its GAAP earnings per share was a loss of $0.01.
The revenue figure reflects income from the company’s business activities before expenses. The per-share loss is an earnings measure calculated under generally accepted accounting principles.